ROSUVASTATINE ZENTIVA 5 mg, film-coated tablet 90 tablets, CIP 3400930022542
Active ingredients: Rosuvastatin, Rosuvastatin calcium
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet90 tablets, CIP 3400930022542orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ROSUVASTATINE ZENTIVA 5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 90 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Jun 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63201575CIP73002254CIP133400930022542Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ROSUVASTATINE CALCIQUEcomprimé | — | SA |
| ROSUVASTATINEcomprimé | 5 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.